Use of Autologous Leucocyte- and Platelet-Rich Plasma (L-PRP) in the Treatment of Aural Hematoma in Dogs
Articolo
Data di Pubblicazione:
2021
Citazione:
Use of Autologous Leucocyte- and Platelet-Rich Plasma (L-PRP) in the Treatment of Aural Hematoma in Dogs / R. Perego, E. Spada, E. Moneta, L. Baggiani, D. Proverbio. - In: VETERINARY SCIENCES. - ISSN 2306-7381. - 8:9(2021 Aug 28), pp. 172.1-172.16. [10.3390/vetsci8090172]
Abstract:
Leukocyte- and platelet-rich plasma (L-PRP) can accelerate the healing process by providing
increased concentrations of platelet-derived growth factors. The objective of this study was to evaluate
the clinical effect of L-PRP in the treatment of canine aural hematomas associated with otitis externa.
Twenty mL of citrated whole blood was collected from each of the 17 dogs included and autologous L-
PRP was produced. The aural hematoma was drained and 0.5–1 mL of L-PRP was injected. The dogs
were examined weekly until 7 days after complete clinical healing. A final clinical follow-up was
performed 6 weeks after the first treatment with L-PRP. If there was recurrence of the aural hematoma
at the first follow-up, the treatment was repeated. In total, 2/17 cases were lost after the first follow-
up. In 5/17 dogs, a short-term recurrence occurred. In 12/15 cases, complete clinical resolution
was achieved with a single L-PRP application (Group A1) and in 3/15 with two treatments (Group
A2). The mean time to complete clinical resolution was 16 ±8.7 days (A1) and 23.3 ±4 days (A2),
respectively. No side effects were reported. The in situ administration of autologous L-PRP resulted
in a complete resolution of the aural hematoma in all dogs that completed the clinical trial.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
aural hematoma; leucocyte- and platelet-rich plasma; dog; treatment;
Elenco autori:
R. Perego, E. Spada, E. Moneta, L. Baggiani, D. Proverbio
Link alla scheda completa:
Link al Full Text: